[Expressions of bFGF and PTEN in cervical carcinoma and their clinical significance].
Luo
Chun-fang
CF
Department of Obstetrics and Gynecology, The Third Hospital of Wuhan, Wuhan 430060, China. chfl2001@hotmail.com
Hong
Hui-li
HL
Lu
Yu-lan
YL
Wang
Hui
H
Liu
Ming-qiu
MQ
D000230:Adenocarcinoma / Q000378:metabolism / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D002584:Cervix Uteri / Q000166:cytology / Q000378:metabolism; D004848:Epithelium / Q000378:metabolism; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D051059:PTEN Phosphohydrolase / Q000378:metabolism*; D002583:Uterine Cervical Neoplasms / Q000378:metabolism* / Q000473:pathology; D055815:Young Adult
D016222:Fibroblast Growth Factor 2; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human